Company
Headquarters: Kaohsiung, Taiwan
TW$8.69 Billion
TWD as of Jan. 1, 2025
US$264.7 Million
| Company | Market Cap (USD) |
|---|---|
| Intuitive | $216.79 B |
| EssilorLuxottica SA | $116.96 B |
| Becton, Dickinson and Company | $69.74 B |
| HOYA Corp | $45.26 B |
| Alcon Inc. | $41.55 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
SciVision Biotech Inc. manufactures and sells hyaluronic acid products in Taiwan. It offers synovial fluid supplements, facial dermal implants, absorbable adhesion barriers, and intravesical instillation products. The company was founded in 2001 and is based in Kaohsiung, Taiwan.
SciVision Biotech, Inc. has the following listings and related stock indices.
Stock: TWSE: 1786 wb_incandescent